SPOTLIGHT -
IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.
Read More